GARABED EKNOYAN to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications GARABED EKNOYAN has written about Randomized Controlled Trials as Topic.
Connection Strength
0.505
-
Clinical trials in uremia-time to reappraise. J Ren Nutr. 2015 Mar; 25(2):250-5.
Score: 0.319
-
Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials. 2000 Oct; 21(5):502-25.
Score: 0.119
-
Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis. 1999 Jan; 33(1):142-9.
Score: 0.026
-
Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. Nephrol Dial Transplant. 2012 Feb; 27(2):640-6.
Score: 0.016
-
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010 Apr; 77(7):624-9.
Score: 0.014
-
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2006 Apr; 47(4):614-24.
Score: 0.011